Welcome to our dedicated page for Adtalem Global Ed news (Ticker: ATGE), a resource for investors and traders seeking the latest updates and insights on Adtalem Global Ed stock.
Adtalem Global Education operates a portfolio of specialized institutions serving healthcare and professional education markets, making its news coverage relevant for investors tracking enrollment trends, regulatory developments, and institutional partnerships. The company's news typically reflects developments across multiple educational brands operating in distinct market segments.
Earnings announcements reveal enrollment patterns across nursing, medical, veterinary, and professional certification programs. Since tuition represents the primary revenue source, enrollment trends directly impact financial performance. Quarterly reports often discuss segment performance, showing how different institutions contribute to overall results and highlighting growth or contraction in specific program areas.
Partnership announcements indicate strategic positioning within healthcare education. Collaborations with healthcare systems create clinical training opportunities essential for nursing and medical programs. Technology partnerships affect educational delivery capabilities and online program expansion. These relationships influence the company's ability to scale programs and maintain accreditation requirements for clinical placements.
Regulatory and accreditation news carries significant weight for Adtalem. Changes to federal student aid policies, accreditation standards, or state licensing requirements affect operational parameters. For-profit education faces ongoing regulatory scrutiny around student outcomes and debt loads, making compliance-related announcements material to understanding the operating environment.
Executive appointments and organizational changes reflect strategic priorities. Leadership shifts in individual institutions or at the corporate level can signal operational adjustments or strategic pivots. Management commentary during earnings calls provides context on competitive positioning, enrollment initiatives, and responses to industry trends affecting healthcare workforce demand.
This news coverage helps investors understand how enrollment cycles, regulatory changes, healthcare workforce dynamics, and educational delivery innovations affect a multi-institutional education company operating across diverse program types and geographic markets.
Chamberlain University and the Oncology Nursing Society (ONS) have launched a free 16-week Introduction to Oncology Nursing course as part of the Practice Ready. Specialty Focused.™ (PRSF) initiative. The program, funded by the American Nurses Foundation, aims to address the national nursing shortage by providing pre-licensure students with specialized healthcare training.
The course is available online and across all 23 Chamberlain campuses, offering four modules: Cancer Basics, Cancer Treatment Modalities, Symptom Management, and Cancer Treatment and Beyond. From January 2022 through May 2024, the PRSF program has enrolled 2,263 students with a 90% completion rate. Additional PRSF courses include emergency nursing, perioperative, home health nursing, nephrology, and critical care nursing.
Adtalem Global Education (ATGE) reported strong Q2 FY2025 results with significant growth across key metrics. Total enrollment reached 91,264, up 11.6% year-over-year, while revenue increased 13.9% to $447.7 million. The company achieved diluted earnings per share of $1.98 and adjusted EPS of $1.81, representing 47.2% growth.
Notable highlights include Chamberlain University's eighth consecutive quarter of enrollment growth (up 11.5%) and Walden University's sixth straight quarter of growth (up 13.2%). The company demonstrated strong financial management by repurchasing $38 million in shares and repaying $100 million of Term Loan B.
Based on these results, Adtalem raised its FY2025 guidance, projecting revenue between $1,730-$1,760 million and adjusted earnings per share of $6.10-$6.30, representing growth of 21.5-25.5% year-over-year.
Adtalem Global Education (NYSE: ATGE), the leading healthcare educator in the United States, has scheduled its second quarter fiscal year 2025 financial results announcement for Thursday, January 30, 2025, after market close. The company will host a conference call at 4:00 p.m. CT (5:00 p.m. ET) on the same day to discuss the results.
Participants can join the call by dialing +1 877-407-6184 (U.S.) or +1 201-389-0877 (international) using conference ID: 13750710. The call will be simulcast through Adtalem's investor relations website, with a replay available for 30 days via phone and website access.
Adtalem Global Education announced that Steve Beard, president and CEO, has been unanimously elected as board chairman, effective immediately. He succeeds Michael W. Malafronte, who transitions to lead independent director. Under Beard's leadership, who joined as CEO in September 2021, Adtalem has transformed into the leading healthcare educator in the U.S., particularly following the Walden University acquisition in August 2021.
The company's Growth with Purpose strategy has shown significant results, with total enrollment exceeding 90,000 students, representing an 11.2% year-over-year growth. Approximately 90% of students are enrolled in healthcare-focused programs, serving over 350,000 alumni.
Adtalem Global Education reported strong Q1 FY2025 results with significant growth across key metrics. Revenue increased 13.2% year-over-year to $417.4 million, while total enrollment grew 11.2% to 90,140 students. Chamberlain University achieved record enrollment with 11.7% growth, and Walden University saw 12.2% enrollment growth. The company reported diluted EPS of $1.18 and adjusted EPS of $1.29, up 38.7% YoY. Based on strong performance, Adtalem raised its FY2025 guidance, projecting revenue of $1,690-$1,730 million and adjusted EPS of $5.75-$5.95.
Adtalem Global Education Inc. (NYSE: ATGE), the leading healthcare educator in the United States, has announced its upcoming first quarter fiscal year 2025 results release and conference call. The company will release its financial results on Tuesday, Oct. 29, 2024, after the financial markets close. This will be followed by a conference call at 4:00 p.m. CT (5:00 p.m. ET) on the same day to discuss the results.
Participants can access the call by dialing +1 877-407-6184 (U.S.) or +1 201-389-0877 (international) and stating "Adtalem earnings call" or using conference ID: 13749198. The call will also be simulcast through the Adtalem investor relations website. A replay of the call will be archived for 30 days, accessible via phone or the company's investor relations website.
Hippocratic AI and Adtalem Global Education (NYSE: ATGE) have partnered to develop a comprehensive educational curriculum to train clinicians on using AI in healthcare. This collaboration aims to integrate nurses' practical experience with advanced AI capabilities, equipping healthcare professionals with skills to evaluate, navigate, and ethically utilize AI tools in patient care.
The partnership will create the first AI certification focused on nurses' role in understanding, integrating, and supervising AI. The curriculum, expected to launch in Spring 2025, will cover topics such as AI and generative AI introduction, AI tools and technologies, nursing applications, clinical workflow integration, and ethical and regulatory considerations. Upon completion, eligible students at Adtalem's Chamberlain University and Walden University will earn a certification.
Adtalem Global Education (NYSE: ATGE) has appointed Sara Hill as Chief Human Resources Officer, effective September 9, 2024. Hill joins from Intricon, where she served as CHRO for four years. With over 25 years of HR experience, Hill has worked at global companies including Ceridian, U.S. Bancorp, and Fidelity Investments. At Adtalem, she will lead the HR function, supporting business objectives and enhancing organizational culture.
Hill's role will involve being a strategic partner to CEO Steve Beard, the leadership team, and the board of directors. She will be responsible for executing HR strategies and leading enterprise-wide strategic change as Adtalem pursues accelerated growth in the healthcare education sector.
Adtalem Global Education (NYSE: ATGE) has appointed Mark E. Rosenberg, MD, FASN, as the new dean of the American University of the Caribbean School of Medicine (AUC), effective September 11. Dr. Rosenberg brings over 40 years of experience in medical practice, education, research, and leadership. He previously served as vice dean of education and academic affairs at the University of Minnesota Medical School for 12 years. His appointment aims to lead AUC's strategic vision for growth, academic excellence, and student outcomes, ultimately contributing to Adtalem's goal of expanding access to quality education and addressing the nationwide physician shortage.
Adtalem Global Education (NYSE: ATGE) reported strong fiscal year 2024 results, with total enrollment up 10.0% year-over-year for Q4 and revenue up 9.2% for the fiscal year. Key highlights include:
- Q4 revenue: $409.9 million, up 12.4% YoY
- FY2024 revenue: $1,584.7 million, up 9.2% YoY
- FY2024 diluted EPS: $3.39; Adjusted EPS: $5.01, up 19.0% YoY
- Total student enrollment: 83,321, up 10.0% YoY in Q4
- Chamberlain University: 6th straight quarter of enrollment growth, up 10.4% YoY
- Walden University: 4th straight quarter of enrollment growth, up 11.3% YoY
Adtalem also initiated FY2025 guidance, projecting revenue of $1,660-$1,700 million and adjusted EPS of $5.60-$5.85, exceeding previous projections.
FAQ
What is the current stock price of Adtalem Global Ed (ATGE)?
What is the market cap of Adtalem Global Ed (ATGE)?
